Development of a TCR-like antibody and chimeric antigen receptor against NY-ESO-1/HLA-A2 for cancer immunotherapy

Xin Liu(University of Southern California), Rong‐Fu Wang(Houston Methodist)
Journal for ImmunoTherapy of Cancer
March 1, 2022
Cited by 46


Related Papers